NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Diagnostic Prediction Model for De Novo Metastatic Breast Cancer
Diagnostic Prediction Model for De Novo Metastatic Breast Cancer

NCT07752238

RecruitingN/A

Sponsor: Markusovszky University Teaching Hospital os County Vas

Conditions: Breast Cancer, Metastatic Invasive Breast Cancer

Countries: Hungary

The goal of this observational study is to create a tool to estimate the risk of macroscopic distant tumor spread in women with newly diagnosed breast cancer. The main question it aims to answer is: • Can a model, which combines routine medical information collected at diagnosis, accurately predict if a patient has metastasis large enough to be found during systemic imaging? Researchers will review the past medical records of participants who were treated at a university hospital. Because this study looks at past data, participants will not be asked to do any new tasks, take new tests, or change their medical care.

Eligibility overview

Sex: FEMALE

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Female sex, aged 18 years or older.
* Newly diagnosed invasive breast cancer.
* Case reviewed by the Multidisciplinary Tumour Board at the study site during the inclusion period (between October 1, 2018, and July 31, 2025).
* No history of prior or synchronous invasive malignancies, except for synchronous bilateral breast cancer.
* Intent for primary treatment and clinical management at the study site.
* Availability of longitudinal clinical records throughout the 12-month follow-up period or until death.

Exclusion Criteria:

-Absence of baseline systemic staging.
Locations (1)
  • Szombathely, Vas County, Hungary